NCT04185285 Percutaneous Coronary Intervention Registry FRIBOURG
| NCT ID | NCT04185285 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Freiburg |
| Condition | Coronary Artery Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2015-05-01 |
| Primary Completion | 2017-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,000 participants in total. It began in 2015-05-01 with a primary completion date of 2017-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The registry aims to follow clinically all consecutive patients treated by percutaneous coronary interventions at hospital \& university Fribourg.
Eligibility Criteria
Inclusion Criteria: * All consecutive patients treated by percutaneous coronary intervention at our institution * Able to give informed consent and willing to participate Exclusion Criteria: * Unwillingness to participate * Enable to provide inform consent
Frequently Asked Questions
Who can join the NCT04185285 clinical trial?
This trial is open to participants of all sexes, aged 17 Years or older, up to 120 Years, studying Coronary Artery Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04185285 currently recruiting?
Yes, NCT04185285 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Freiburg to inquire about joining.
Where is the NCT04185285 trial being conducted?
This trial is being conducted at Fribourg, Switzerland.
Who is sponsoring the NCT04185285 clinical trial?
NCT04185285 is sponsored by University of Freiburg. The trial plans to enroll 3,000 participants.